Crowe M, Ashford K, Ispahani P
Department of Microbiology and Public Health Laboratory, Queens Medical Centre, University Hospital, Nottingham, United Kingdom.
J Med Microbiol. 1996 Oct;45(4):302-9. doi: 10.1099/00222615-45-4-302.
Yersinia enterocolitica bone and joint infections are rare. Over a period of 7 months four patients with deep-seated skeletal infections due to Y. enterocolitica were seen at the University Hospital, Nottingham. Sites of infection included the knee (one patient) the hip (one) and the spine (two). None of the patients had major underlying disease or risk factors for developing invasive Y. enterocolitica infection. The organisms were sensitive to the second- and third-generation cephalosporins, gentamicin and fluoroquinolones. A literature search covering the period 1970-1994 revealed 20 other cases of skeletal infections due to Y. enterocolitica; there was no uniformity in the choice of antimicrobial agent for treating these infections. Oral ciprofloxacin was used as the principal antimicrobial agent in the patients described here and therapeutic success was achieved in three of these patients. Ciprofloxacin should be considered as first line therapy for invasive infections due to Y enterocolitica.
小肠结肠炎耶尔森菌引起的骨和关节感染较为罕见。在7个月的时间里,诺丁汉大学医院收治了4例由小肠结肠炎耶尔森菌引起的深部骨骼感染患者。感染部位包括膝关节(1例患者)、髋关节(1例)和脊柱(2例)。所有患者均无严重基础疾病或发生侵袭性小肠结肠炎耶尔森菌感染的危险因素。这些病菌对第二代和第三代头孢菌素、庆大霉素和氟喹诺酮敏感。一项涵盖1970年至1994年期间的文献检索发现了另外20例由小肠结肠炎耶尔森菌引起的骨骼感染病例;在治疗这些感染时,抗菌药物的选择并不统一。本文所述患者以口服环丙沙星作为主要抗菌药物,其中3例患者治疗成功。环丙沙星应被视为侵袭性小肠结肠炎耶尔森菌感染的一线治疗药物。